Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)

NCT02349516 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Study cancelled as of 9/12/15. 0 subjects enrolled.

Conditions

Diabetic Retinopathy

Interventions

DRUG: Squalamine Lactate Ophthalmic Solution 0.2%

Sponsor

Starr Muscle

Collaborators

[object Object]